In late-stage tumors, TGFβ usually functions as a tumor promoter by stimulating epithelial–mesenchymal transition (EMT)—that is, the de-differentiation of epithelial cells to invasive and metastatic mesenchymal-like cells. This evidence concerns the gene TGFB1 and neoplasm.